参考文献/References:
[1] SOERJOMATARAM I, LORTER-TIEULENT J,P-ARKIN D M,et al.Global burden of cancer in 2008:a systematic analysis of disability-adjusted life-years in 12 word regions[J].Lancet,2012,380(9856):1840-1850.
[2] FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):E359-E386.
[3] LIN Quanjun,YANG Feng,JIN Chen,et al.Current status and progress of pancreatic cancer in China[J].World J Gastroenterol,2015,21(26):7988-8003.
[4] SAKAMOTO T,SAITO H,UCHINAKA E I,et al.The combination of neutrophil-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognosticindicator in patients with recurrent pancreatic cancer[J].Anticancer Research,2018,38(9):5497-5503.
[5] YU Jinming,DING Zhaoyan,YANG Yuanming,et al.Increased platelet-to-lymphoctes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgey[J].Medicine(Baltimore),2018,97(25):e11002.
[6] LANASPA M A,SANCHEZ-LOZADA L G,CHOI Y J,et al.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress:potential role infructose-dependent and independent fatty liver[J].The Journal of BiologicalChemistry,2012,287(48):40732-40744.
[7] FABBRINI E,SWRAFINI M,COLIC BARIC I,et al.Effect of plasma uric acidon antioxidant capacity,oxidative stress,and insulin sensitivity in obese subjects[J].Diabetes,2014,63(3):976-981.
[8] LIOU G Y,STORZ P.Reacitve oxygen species in ca-ncer[J].Free Radic Rec,2010,44(5):479-496.
[9] AMES B N,CATHCART R,SCHWIERS E,et al.Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer:a hypothesis[J].Proc Natl Acad Sci USA,1981,78(11):6858-6862.
[10] YUE Caifeng,FENG Pinning,YAO Zhenrong,et al.High serum uricacid concentration predicts poor survival in patients with breast cancer[J].Clin Chim Acta,2017,473:160-165.
[11] STOTZ M,SZKANDERA J,SEIDEL J,et al.Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients[J].PLoS One,2014,9(8):e104730.
[12] TANRIVERDI O,COKMERT S,OKTAY E,et al.Prognostic significance of thebaseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy:a study of the Turkish Descriptive Oncological Researches Group[J].Med Oncol,2014,31(10):217.
[13] FINI M A,ELIAS A,JOHNSON R J,et al.Contribution of uric acid to cancer risk,recurrence,and mortality[J].Clin Transl Mel,2012,1(1):16.
[14] 段敏,赵海建,王薇,等.临床检验参考区间的决定限的质量要求[J].现代检验医学杂志,2017,32(5):148-151.
DUAN Min, ZHAO Haijian, WANG Wei, et al.Quality requirements for reference intervals and decision limits in clinical laboratory[J].J Mod Lab Med,2017,32(5):148-151.
[15] ZHONG Chongke, ZHONG Xiaoyan, XU Tian,et al.Sex-specific relationshipbetween serum uric acid and risk of stroke:A dose-response meta-amalysis ofprospective studies[J].J Am Heart Assoc,2017,6(4):e005042.
[16] GAO Xiang,O'REILLY E J,SCHWARZSCHILD M A,et al.Prospective study ofplasma urate and risk of parkinson disease in men and women[J].Neurology,2016,86(6):520-526.
[17] MOCCIA M,PELLECCHIA MT,SPINA E,et al.Bilirubin and uric acid:two different anti- oxidants in Parkinson's disease[J].Cell Biochem Biophys,2016,74(2):91-92.
[18] LAPENNA D,CIOFANI G,PIERDOMENICO S D,et al.Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis[J].Clin Exp Med,2018,18(1):119-124.
[19] TANG Linghui,HUANG Cheng,FENG Yingqing.Serum total bilirubin concentration is associated with carotid atherosclerosis in patients with prehypertension[J].Clin Exp Hypertens,2018,oct.30:1-5.doi.10.1080110641963.2018.1539094.[Epub ahead of print]
相似文献/References:
[1]陈 宇,倪二茹,杨 新,等.福州市公交司机血糖、尿酸和血脂的调查研究[J].现代检验医学杂志,2016,31(01):149.[doi:10.3969/j.issn.1671-7414.2016.01.044]
CHEN-Yu,NI Er-ru,YANG Xin,et al.Investigation on Serum Glucose,Uric Acid and Lipid
Profile of Professional Bus Drivers in Fuzhou City[J].Journal of Modern Laboratory Medicine,2016,31(04):149.[doi:10.3969/j.issn.1671-7414.2016.01.044]
[2]国钰梅,马 龙,包成月,等.急性缺血性脑卒中患者尿酸水平与出院结局的关联研究[J].现代检验医学杂志,2015,30(03):17.[doi:10.3969/j.issn.1671-7414.2015.03.005]
GUO Yu-mei,MA Long,BAO Cheng-yue,et al.Relationship between Uric Acid Levels in Patients
with Acute Ischemic Stroke and Discharged Outcome[J].Journal of Modern Laboratory Medicine,2015,30(04):17.[doi:10.3969/j.issn.1671-7414.2015.03.005]
[3]党珊a,周健a,杨帆b,等.胰腺癌组织中缺氧诱导因子-2α的表达及临床意义[J].现代检验医学杂志,2015,30(06):32.[doi:10.3969/j.issn.1671-7414.2015.06.009]
DANG Shana,ZHOU Jiana,YANG Fanb,et al.Expression of Hypoxia Inducible Factor 2α in Pancreatic
Carcinoma and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2015,30(04):32.[doi:10.3969/j.issn.1671-7414.2015.06.009]
[4]蒋晶慧,于洪伟,张 泽,等.基于石墨烯量子点构建生物传感器检测尿酸和多巴胺的实验研究[J].现代检验医学杂志,2017,32(04):9.[doi:10.3969/j.issn.1671-7414.2017.04.003]
JIANG Jing-hui,YU Hong-wei,ZHANG Ze,et al.Simultaneous Electrochemical Detection of
Uric Acid and Dopamine Based on Graphene
Quantum Dot Modified Glassy Carbon Electrode[J].Journal of Modern Laboratory Medicine,2017,32(04):9.[doi:10.3969/j.issn.1671-7414.2017.04.003]
[5]邢瑞青,彭道荣,刘 杨.血清CA199，KL-6和PIVKA-Ⅱ水平联合检测在胰腺癌诊断中的应用价值分析[J].现代检验医学杂志,2021,36(05):100.[doi:10.3969/j.issn.1671-7414.2021.05.022]
XING Rui-qing,PENG Dao-rong,LIU Yang.Application Value of Combined Detection of Serum CA199,KL-6 andPIVKA -Ⅱ Levels in the Diagnosis of Patients with Pancreatic Cancer[J].Journal of Modern Laboratory Medicine,2021,36(04):100.[doi:10.3969/j.issn.1671-7414.2021.05.022]
[6]王东琴,霍浩然,秦瑞峰,等.胰腺癌患者血清 lncRNA-SNHG11的表达水平及其临床意义[J].现代检验医学杂志,2022,37(01):125.[doi:10.3969/j.issn.1671-7414.2022.01.025]
WANG Dong-qin,HUO Hao-ran,QIN Rui-feng,et al.Expression Level of Serum lncRNA-SNHG11 in Patients with Pancreatic Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(04):125.[doi:10.3969/j.issn.1671-7414.2022.01.025]
[7]王军堂a,齐普良a,张金刚a,等.hsa_circ_0006950 调控miR-124-3p/EZH2 轴促进胰腺癌细胞增殖与迁移的机制研究[J].现代检验医学杂志,2022,37(05):93.[doi:10.3969/j.issn.1671-7414.2022.05.019]
WANG Jun-tanga,QI Pu-lianga,ZHANG Jin-ganga,et al.Mechanism of hsa_circ_0006950 Regulating miR-124-3p /EZH2 Axis to Promote the Proliferation and Migration of Pancreatic Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(04):93.[doi:10.3969/j.issn.1671-7414.2022.05.019]
[8]张莉娜,张霁雯,罗 酩,等.胰腺癌组织CTTN 和miR-545-3p 表达水平及其与临床病理和预后的相关性研究[J].现代检验医学杂志,2022,37(06):99.[doi:10.3969/j.issn.1671-7414.2022.06.018]
ZHANG Li-na,ZHANG Ji-wen,LUO Ming,et al.Expression Levels of CTTN and miR-545-3p in Pancreatic Cancer Tissues and Their Correlation with Clinicopathology and Prognosis[J].Journal of Modern Laboratory Medicine,2022,37(04):99.[doi:10.3969/j.issn.1671-7414.2022.06.018]
[9]张立洁a,彭 泉b.基于GEO 数据库筛选慢性胰腺炎恶变过程中关键miRNA 和ceRNA 网络构建[J].现代检验医学杂志,2023,38(02):18.[doi:10.3969/j.issn.1671-7414.2023.02.004
]
ZHANG Li-jiea,PENG Quanb.Screening of Key miRNAs and Construction of Competing Endogenous RNA Network Involved in the Progression from Chronic Pancreatitis to Pancreatic Cancer Based on GEO Database[J].Journal of Modern Laboratory Medicine,2023,38(04):18.[doi:10.3969/j.issn.1671-7414.2023.02.004
]
[10]檀占海,陈建荣,张吉发,等.胰腺癌组织中METTL14 和GFPT1 的水平表达与临床预后价值研究[J].现代检验医学杂志,2023,38(05):99.[doi:10.3969/j.issn.1671-7414.2023.05.019]
TAN Zhanhai,CHEN Jianrong,ZHANG Jifa,et al.Expression of METTL14 and GFPT1 in Pancreatic Cancer and Their Clinical Prognostic Value[J].Journal of Modern Laboratory Medicine,2023,38(04):99.[doi:10.3969/j.issn.1671-7414.2023.05.019]